A study of analyst recommendations at the major brokerages shows that Merck & Co., Inc. is the #15 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel.
Feinstein Doyle Payne & Kravec LLC and Sanford Heisler, LLP have revealed that more than 400 women had already reached out with discrimination claims relating to the $250 million women discrimination class action lawsuit against Merck & Co., Inc.
Among pharmaceutical companies, Merck & Co. (NYSE:MRK) and AbbVie (NYSE:ABBV) have been two of the most successful and profitable over the long run, and their share prices have posted impressive long-term returns for shareholders.
When speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how Merck & Co. Inc. (NYSE:MRK)'s stock has performed at various points in its past. Currently, the stock ...